Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
A Standard patent application filed on 28 May 1998 credited to Myers, Michael
;
Maguire, Martin P.
;
Persons, Paul E
;
Spada, Alfred P.
Details
Application number :
77062
Application type :
Standard
Application status :
CEASED
Under opposition :
No
Proceeding type :
Invention title :
Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases
Inventor :
Myers, Michael
;
Maguire, Martin P.
;
Persons, Paul E
;
Spada, Alfred P.
Agent name :
WATERMARK PATENT AND TRADE MARKS ATTORNEYS
Address for service :
Level 2 302 Burwood Road HAWTHORN VIC 3122
Filing date :
28 May 1998
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc.
Applicant address :
55 Corporate Drive, Bridgewater, New Jersey, 08807 United States Of America
Old name :
Aventis Pharmaceuticals Products Inc.
;
Rhone-Poulenc Rorer Pharmaceuticals Inc.